PROFILE |
 |
Detecting parasitic, gastrointestinal, respiratory, urogenital, and viral diseases is the high point for Meridian Bioscience (formerly Meridian Diagnostics). The firm's test kits are used to analyze blood, urine, and other bodily fluids and tissues and detect antibodies produced in response to bacteria, viruses, and foreign substances. The kits aid in the diagnosis of gastrointestinal infections, mononucleosis, and strep throat, as well as in the detection of diseases that affect patients with cancer, AIDS, and other immunosuppressive conditions. All of the firm's products are used in procedures performed in vitro (outside the body). Cofounder and chairman William Motto owns almost one-third of Meridian.
COMPETITION |
 |
Abbott Laboratories (ABT)
Becton, Dickinson and Company (BDX)
Diagnostic Products Corporation (DP)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: September
2000 Sales (mil.): 57.10
1-Yr. Sales Growth: 5.0%
Employees: 369
Revenue per employee: $154,742.55
KEY PEOPLE |
 |
William J. Motto
CEO
Melissa A. Lueke
CFO
CONTACT INFO |
 |
3471 River Hills Dr.
Cincinnati, OH 45244
US
Phone: 513-271-3700
Fax: 513-271-3762
Online: Web Site
|